Isabella Giacchetto-Sasselli

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

J. Skehel, D. Jarrossay, F. Sallusto, 2011, Science.

A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients

R. Geiger, D. Jarrossay, F. Sallusto, 2019, Nature Medicine.

Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody

M. Beltramello, A. Telenti, J. Bloom, 2021, bioRxiv.

Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland

E. Bernasconi, I. Bartha, F. Sallusto, 2020, The Lancet Regional Health - Europe.

Broad sarbecovirus neutralization by a human monoclonal antibody

M. Beltramello, A. Telenti, J. Bloom, 2021, Nature.

Rapid development of broadly influenza neutralizing antibodies through redundant mutations

Qing Zhu, Mathilde Foglierini, Leontios Pappas, 2014, Nature.

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

J. Skehel, D. Jarrossay, F. Sallusto, 2011, Science.